Our Story
Iridescent Sensors Inc. was founded in late 2022 to further commercialize the colorimetric sensor array technology developed and patented at the University of Illinois at Urbana-Champaign by Ken Suslick (our CEO) and Jon Askim (our CTO).
Previously, this technology was successfully commercialized for rapid bacterial detection and sepsis diagnosis by Specific Diagnosis Inc. (co-founded by Ken Suslick). In 2023, BioMérieux (the French biotech giant) acquired Specific Diagnosis for $430 million.
Meet the Leadership Team
Iridescent Sensors has established a deep technical organization with leadership that combines expertise in the development, scale-up, and commercialization of colorimetric sensor array technologies, business development and sales.
Iridescent Sensors is funded in part
by the NSF Convergence Accelerator.